Herbal hope: new study tests traditional chinese medicine against lung cancer return

NCT ID NCT05834413

First seen May 15, 2026 · Last updated May 16, 2026 · Updated 1 time

Summary

This study is testing whether adding Chinese herbal medicine to standard chemotherapy and immunotherapy can prevent lung cancer from returning after surgery. About 367 adults with a certain type of lung cancer (non-small cell, stage Ib to IIIb, without driver gene mutations) will be split into two groups: one gets standard treatment alone, the other gets standard treatment plus herbal medicine. Researchers will track how long participants stay cancer-free and their quality of life over 4 years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • YueYang Hosptial of Intergrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine

    RECRUITING

    Shanghai, Shanghai Municipality, 200437, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.